The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …
How popular are OTC products in the CIS countries in 2013?
Report compares, analyses market data and forecasts for Russia, Ukraine and Kazakhstan.
Over the counter drugs and a growing selection of dietary supplements are gaining popularity among health conscious people everywhere. Consequently, the markets for these preparations are expanding across the CIS region, particularly in the countries of Russia, Ukraine and Kazakhstan. Opportunities exist for businesses involved in the manufacture, distribution and wholesale and retail sales of these products in the years ahead.
To alert industry professionals of important upcoming events in the market, PMR has prepared the newest edition of its report – OTC market in CIS countries 2013, Russia, Ukraine and Kazakhstan. Comparative analysis and development forecasts for 2013-2015. It contains comprehensive descriptions of the markets in each country, plus consumer preference data, detailed forecasts and profiles of the major manufacturers.
This report gathers and presents a wealth of expert analysis and historical data that comes as a result of years of close observation of the market by the PMR team of experienced analysts. It presents market data from each of the three covered countries in a manner that facilitates comparison among the markets and makes important decision-making and strategic planning simpler and more accurate. Readers will discover which country offers the greatest room for growth and the most valuable OTC market for drugs and dietary supplements.
This publication features coverage of trends in each country, as well as the top selling over the counter remedies. It details the value and structure of OTC markets and their main segments, while examining the share of the overall pharmaceutical markets in each country occupied by the OTC industry. The profiles of leading OTC manufacturers in the region are presented, along with consumer preferences and purchasing habits.
The report examines key market trends and predicts their likely impact on sales over the forecast period, along with the strategic choices that companies are willing to make in order to increase market share. It considers spending on advertising and other strategies being used by companies to expand the marketplace.
OTC manufacturing, sales and distribution professionals will turn to this valuable document when they need to evaluate the competition, choose a new location for an expansion or create a new sales strategy for a particular type of OTC product. Financial services, consulting and research service providers use it to locate and serve new clients with interests in this market, and government agencies consult its pages when assessing the effects of old regulations on market value or developing new legislation for the pharmaceutical sectors in each of the three CIS countries covered by OTC market in CIS countries 2013, Russia, Ukraine and Kazakhstan. Comparative analysis and development forecasts for 2013-2015.